Lerochol Injection, Solution
Product Images NDC 84685-300

Product Visual Gallery

This gallery contains 25 technical images submitted to the FDA as part of the official labeling for Lerochol (NDC 84685-300). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lib Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ler00 0001 01)

A line graph showing LDL cholesterol percent change from baseline over 52 weeks comparing LEROCHOL 300 mg once monthly injection versus placebo. The y-axis represents LDL cholesterol percent change, and the x-axis represents time points from baseline to week 52, with data points and sample sizes indicated for each group.*

FDA Label Image

Figure 2 (Ler00 0001 02)

A line graph comparing the mean percent change in LDL cholesterol from baseline over 52 weeks for LEROCHOL 300 mg once monthly injection versus placebo once monthly. The x-axis shows time points from baseline through week 52, and the y-axis shows percent change. LEROCHOL shows a significant decrease while placebo remains near baseline.*

FDA Label Image

Figure (Ler00 0001 03)

A line graph comparing LDL cholesterol percent change from baseline between LEROCHOL 300 mg once monthly and placebo once monthly over 24 weeks. The x-axis shows time points from baseline to week 24, and the y-axis represents percent change in LDL cholesterol. LEROCHOL shows a substantial decrease in LDL levels while placebo remains near baseline.*

FDA Label Image

Figure A (Ler00 0001 04)

An instructional diagram showing a syringe labeled with medicine and expiration date before use, highlighting components such as the plunger rod, barrel, needle cap, and needle. The after-use image depicts the syringe with the plunger fully depressed and the needle exposed.*

FDA Label Image

Figure B (Ler00 0001 05)

An instructional illustration showing medical supplies: a carton containing a prefilled syringe, an alcohol wipe, a cotton ball or gauze, an adhesive bandage, and a sharps disposal container. Each item is labeled clearly for identification.*

FDA Label Image

Figure C (Ler00 0001 06)

An instructional illustration showing a clock with "WAIT 30 minutes" inside it, positioned above a rectangular box, likely indicating a waiting period of 30 minutes before or after handling the product packaging.*

FDA Label Image

Figure D (Ler00 0001 07)

An instructional illustration showing a hand holding an opened box and removing a small rectangular item, possibly a medication package or vial, while another hand is positioned below to receive it. The image likely demonstrates how to take the product out of its packaging.*

FDA Label Image

Figure E (Ler00 0001 08)

An instructional illustration showing a person peeling back the adhesive backing from a rectangular medical patch or device packaging, preparing it for application or use.*

FDA Label Image

Figure F (Ler00 0001 09)

An instructional illustration showing a hand holding a subcutaneous injection device, demonstrating a rotating motion on the device likely as part of the injection preparation or administration process.*

FDA Label Image

Figure G (Ler00 0001 10)

An instructional illustration showing a hand holding a prefilled syringe, demonstrating the process of preparing for a subcutaneous injection. The image depicts the syringe positioned above the other hand, indicating correct handling and administration technique for the injection solution.*

FDA Label Image

Figure H (Ler00 0001 11)

An illustration of a hand holding a subcutaneous injection syringe, likely depicting the administration method for LEROCHOL 300 mg/1.2 mL injection solution by LIB Therapeutics, Inc.*

FDA Label Image

Figure I (Ler00 0001 12)

Illustration showing a syringe filled with a liquid solution labeled for injection use, with an enlarged view highlighting the expiration date format as EXP YYYY MO DY, indicating where to find the expiration date on the syringe.*

FDA Label Image

Figure J (Ler00 0001 13)

An illustration of a prefilled syringe with a magnified inset showing the measurement markings on the syringe barrel. The syringe is designed for subcutaneous injection.*

FDA Label Image

Figure K (Ler00 0001 14)

An instructional illustration showing hands being washed under running water from a faucet. The image demonstrates proper handwashing technique, likely for hygiene before handling medication or injection.*

FDA Label Image

Figure L (Ler00 0001 15)

An anatomical illustration of a human body from the front showing recommended injection sites. The upper arms are shaded with a pattern indicating caregiver and doctor only administration. The abdomen around the navel and the front thighs are shaded solid black indicating areas for both self-injection and caregiver or doctor injection.*

FDA Label Image

Figure M (Ler00 0001 16)

An instructional illustration showing a hand holding a small rectangular item, possibly a piece of medication or a patch, being placed on or picked up from a flat surface.*

FDA Label Image

Figure N (Ler00 0001 17)

An instructional diagram showing a hand inserting a small vial or cartridge into a syringe device. The image includes a close-up inset illustrating how to align or place the vial properly. An arrow indicates the direction for inserting the vial. The hands demonstrate the assembly process of the injection device components.*

FDA Label Image

Figure O (Ler00 0001 18)

An instructional illustration showing a hand holding a syringe inserted into skin at a 45-degree angle, with a smaller diagram indicating the angle between 45 and 90 degrees. It demonstrates proper subcutaneous injection technique.*

FDA Label Image

Figure P (Ler00 0001 19)

An instructional illustration depicting a hand holding a syringe with the other hand pressing down on the plunger, demonstrating the injection technique for a subcutaneous injection.*

FDA Label Image

Figure Q (Ler00 0001 20)

An instructional illustration showing a hand holding a syringe for subcutaneous injection. The image depicts the needle angled upwards, poised to administer the injection under the skin.*

FDA Label Image

Figure R (Ler00 0001 21)

An instructional illustration showing a hand holding a cotton ball or gauze pad, likely demonstrating its use on an injection site. The image is simple and monochrome, focusing on technique for subcutaneous injection site care.*

FDA Label Image

Figure S (Ler00 0001 22)

An instructional illustration showing a hand disposing of a syringe by placing it into a sharps disposal container. The image emphasizes proper syringe disposal technique.*

FDA Label Image

Principal Display Panel – 300 mg/1.2 mL Carton Label (Ler00 0001 23)

Carton label for LEROCHOL (lerodalcibep-liga) Injection, 300 mg/1.2 mL (250 mg/mL) single-dose prefilled syringe. The label indicates subcutaneous administration, storage instructions, and manufacturer LIB Therapeutics, Inc. Barcodes and additional product information are visible.*

FDA Label Image

Principal Display Panel – 300 mg/1.2 mL Tray Label (Ler00 0001 24)

LEROCHOL 300 mg/1.2 mL (250 mg/mL) injection, solution in a single-dose prefilled syringe for subcutaneous use. The label lists inactive ingredients and storage instructions, noting refrigeration at 36°F to 46°F and to avoid freezing or shaking. Manufactured by LIB Therapeutics, Inc.*

FDA Label Image

Principal Display Panel – 300 mg/1.2 mL Prefilled Syringe Label (Ler00 0001 25)

Label of LEROCHOL (lerodalcibep-liga) Injection, a 300 mg/1.2 mL (250 mg/mL) subcutaneous injection solution in a single-dose prefilled syringe. The label states it is sterile with no preservative and includes instructions to discard unused portion. Manufactured by LIB Therapeutics, Inc., Cincinnati, OH.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.